Eric Ka‐Chai Lee

Tuen Mun Hospital

Papers

1

Total Citations

8

H-Index

1

About

Dr. Eric Ka-Chai Lee is a distinguished urological oncologist whose work focuses on prostate cancer management, particularly during public health crises. His most-cited paper, "Prostate cancer management in the era of COVID‐19," reflects his leadership in developing interdisciplinary care protocols that address the unique challenges posed by the pandemic. This work, with 8 citations, offers critical recommendations for coordinating treatment across specialties when resources are strained. Dr. Lee’s contributions extend to advancing surgical techniques and optimizing patient outcomes in uro-oncology, with a particular emphasis on adapting evidence-based practices to real-world constraints. His research has shaped clinical guidelines in Hong Kong and beyond, demonstrating the importance of resilient healthcare systems. Through his roles in the Hong Kong Urological Association and Hong Kong Society of Uro-oncology, Dr. Lee has championed collaborative approaches that bridge clinical expertise and public health needs. His work continues to influence how urologists manage prostate cancer under challenging circumstances, ensuring that patients receive timely, effective care even during global disruptions.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Prostate cancer management in the era of COVID‐19: Recommendations from the Hong Kong Urological Association and Hong Kong Society of Uro‐oncology
8 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Tuen Mun Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago